Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey
BackgroundA digital tool, Multiple Sclerosis Progression Discussion Tool (MSProDiscuss), was developed to facilitate discussions between health care professionals (HCPs) and patients in evaluating early, subtle signs of multiple sclerosis (MS) disease progression. ObjectiveThe aim of this study is t...
Saved in:
Main Authors: | Tjalf Ziemssen (Author), Gavin Giovannoni (Author), Enrique Alvarez (Author), Virender Bhan (Author), Carrie Hersh (Author), Olaf Hoffmann (Author), Celia Oreja-Guevara (Author), Rene R Robles-Cedeño (Author), Maria Trojano (Author), Patrick Vermersch (Author), Pamela Dobay (Author), Mudeer Khwaja (Author), Bianca Stadler (Author), Benedict Rauser (Author), Thomas Hach (Author), Daniela Piani-Meier (Author), Jason Burton (Author) |
---|---|
Format: | Book |
Published: |
JMIR Publications,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study
by: Ziemssen, Tjalf, et al.
Published: (2020) -
Usability Assessment Methods for Mobile Apps for Physical Rehabilitation: Umbrella Review
by: Sylvia Hach, et al.
Published: (2024) -
"Der ,Digitale Zwilling' kann die MS-Versorgung wirklich verbessern"
by: Univ.-Prof. Dr. med. Tjalf Ziemssen, et al.
Published: (2023) -
The need for a strategic therapeutic approach: multiple sclerosis in check
by: Hernan Inojosa, et al.
Published: (2022) -
Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab
by: Tjalf Ziemssen, et al.
Published: (2024)